Medtronic (NYSE:MDT) said today that it launched its Control Workflow system in the U.S. for use with its SynchroMed II intrathecal drug-delivery system.
The medtech titan is hoping that, combined with its pain pump, the workflow system can help physicians in weaning patients off oral opioids. In a retrospective claims analysis, Medtronic found that 51% of chronic non-malignant pain patients stopped using oral opioids after one year on the SynchroMed II pump.
Get the full story at our sister site, Drug Delivery Business News.
The post Medtronic launches workflow system to help wean patients off oral opioids appeared first on MassDevice.
from MassDevice https://ift.tt/2ylhjDD
Cap comentari:
Publica un comentari a l'entrada